Bioequivalence of IR vs MR tablet [Design Issues]

posted by heritage – India, 2018-05-05 06:25 (1102 d 02:09 ago) – Posting: # 18755
Views: 2,916

One drug has been approved as IR tablet given 100 mg bid (total dose 200 mg). We want to make one ER formulation of 230 mg which can be given once daily. I need help in following issues

1. What should be the design?
2. Which PK parameter I should be looking at?
3. Should I do fasting or fed study?
4. Should I targeting BE in Cmax or AUC?

Please give me some reading material or link to any post wherein this had been already discussed

Thanks in advance

Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

 Admin contact
21,446 posts in 4,483 threads, 1,511 registered users;
online 17 (0 registered, 17 guests [including 11 identified bots]).
Forum time: Tuesday 08:34 CEST (Europe/Vienna)

The fact that some geniuses were laughed at
does not imply that all who are laughed at are geniuses.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz